相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway
Guohua Lou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
RNA delivery by extracellular vesicles in mammalian cells and its applications
Killian O'Brien et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Exosomes as a Multicomponent Biomarker Platform in Cancer
Valerie S. LeBleu et al.
TRENDS IN CANCER (2020)
A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice
Seungho Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles
Sara Busatto et al.
BIOMEDICAL MICRODEVICES (2019)
NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis
Guangyan Zhou et al.
NUCLEIC ACIDS RESEARCH (2019)
A novel technique to prepare a single cell suspension of isolated quiescent human hepatic stellate cells
Xiangyu Zhai et al.
SCIENTIFIC REPORTS (2019)
A cAbl-MRTF-A Feedback Loop Contributes to Hepatic Stellate Cell Activation
Yunjie Lu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis
Dai-Min Xiang et al.
GUT (2018)
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan et al.
MATRIX BIOLOGY (2018)
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Jenny D. Beebe et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Generation and testing of clinical-grade exosomes for pancreatic cancer
Mayela Mendt et al.
JCI INSIGHT (2018)
Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury
Elena Arriazu et al.
GUT (2017)
Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation
Ying Qu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A
Miljdat Zeybel et al.
MOLECULAR THERAPY (2017)
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar et al.
NATURE (2017)
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Debomita Chakraborty et al.
NATURE COMMUNICATIONS (2017)
Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice
Kwang Hwa Jung et al.
CLINICAL CANCER RESEARCH (2017)
Extracellular vesicles for drug delivery
Pieter Vader et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
Mercedes Tkach et al.
CELL (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice
Hideyuki Ogiso et al.
PLOS ONE (2016)
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
Sara Lovisa et al.
NATURE MEDICINE (2015)
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
Tung-Hung Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A comprehensive overview of exosomes as drug delivery vehicles - Endogenous nanocarriers for targeted cancer therapy
Kasper Bendix Johnsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Overexpression of miR-126 Inhibits the Activation and Migration of HSCs through Targeting CRK
Xu-Hua Gong et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Biogenesis and secretion of exosomes
Joanna Kowal et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Routes and mechanisms of extracellular vesicle uptake
Laura Ann Mulcahy et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
TGF-β1-Containing Exosomes from Injured Epithelial Cells Activate Fibroblasts to Initiate Tissue Regenerative Responses and Fibrosis
Fernanda T. Borges et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
STAT3-Mediated Signaling Dysregulates Lung Fibroblast-Myofibroblast Activation and Differentiation in UIP/IPF
Dmitri V. Pechkovsky et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Hepatoprotective versus Oncogenic Functions of STAT3 in Liver Tumorigenesis
Hua Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Pathogenesis of Liver Fibrosis
Virginia Hernandez-Gea et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target
Hua Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez-Erviti et al.
NATURE BIOTECHNOLOGY (2011)
SiRNA delivery with exosome nanoparticles
Jasper G. van den Boorn et al.
NATURE BIOTECHNOLOGY (2011)
Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis
Carolin Lackner et al.
JOURNAL OF HEPATOLOGY (2008)
Thrombospondin 1 acts as a strong promoter of transforming growth factor β effects via two distinct mechanisms in hepatic stellate cells
K Breitkopf et al.
GUT (2005)
分享论文
